Tailored One Anastomosis Gastric Bypass
Recruiting · NCT06829381 · Interventional (participants receive a specific treatment) · Lead sponsor: Tel-Aviv Sourasky Medical Center
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
One Anastomosis Gastric Bypass (OAGB) is the most common metabolic and bariatric surgery (MBS) in Israel, recognized for its effectiveness in achieving sustainable weight loss and mitigating obesity-related diseases. The metabolic outcomes of OAGB are significantly influenced by the length of the biliopancreatic limb (BPL). The objective of this study is to determine whether tailoring the BPL length to the total small bowel length (TSBL) results in more effective weight loss compared to patients undergoing OAGB with a fixed BPL of 180 cm. Efficacy and safety of this approach will also be evaluated, ensuring it does not lead to long-term morbidity or negatively impact patients' quality of life.
Who can take part
Inclusion criteria
- Adults (≥18 years) undergoing OAGB
Exclusion criteria
- Patients \<18 years, pregnant women, or those lacking decision-making capacity Prior bariatric surgery Short bowel (\<450 cm)
Where it is running
1 location listed.
- Tel Aviv Sourasky Medical Center - Tel Aviv, Israel